Someone started buying this morning... Paying all the way up to $2.28 per share... Did they know something we don't?
10-11-2013 Zacks upgraded shares of Solta Medical Inc. from an underperform rating to a neutral rating. Zacks now has a $2.30 price target
I bought more at 2.15
MMs sucking in more bagholders with headfake